chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Symptoms began approx. 17:30 on 8/14/01 with nausea and fatigue. On 8/15/01, the pt had chills, fever, muscle pain (neck and legs), SOB, chest constriction, headache, diaphoresis and unable to sleep. On 8/15/01, developed SOB. On 8/16/01, had muscle cramps and chest discomfort and on 8/17/01, had muscle pain and chest discomfort. Appt. scheduled for 8/17/01.
ACUTE KIDNEY INJURY; UNCONTROLLED HYPERTENSION; ELEVATED SEDIMENTATION RATE; ELEVATED C REACTIVE PROTEIN; ELEVATED LIVER FUNCTION TESTS; DAILY PERSISTENT HEADACHE; This spontaneous report received from a pharmacist concerned a 61 year old female. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. It was reported that, the patient received care at the clinic. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 042A21A, expiry: UNKNOWN) 1 total, dose was not reported, administered on 07-APR-2021 for prophylactic vaccination. No concomitant medications were reported.  On an unspecified date, the patient had acute kidney injury, uncontrolled hypertension, elevated sedimentation rate, elevated c reactive protein, elevated liver function tests, and daily persistent headache. The patient visited doctor/healthcare professional office for the events. The patient's laboratory data included blood pressure (not reported), C-reactive protein elevated, erythrocyte sedimentation rate elevated, and Liver function tests elevated. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from uncontrolled hypertension, elevated sedimentation rate, elevated c reactive protein, daily persistent headache, elevated liver function tests, and acute kidney injury. This report was serious (Other Medically Important Condition).; Sender's Comments: V0-20210537406-COVID-19 VACCINE AD26.COV2.S-Acute Kidney Injury. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).
Information has been received from a lawyer regarding a case in litigation concerning a female patient of unknown age. No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication. On or about 05-MAR-2015, the patient was inoculated with ZOSTAVAX (lot number, dosage and route of administration not provided), as recommended for routine adult health maintenance and for the prevention of shingles. The ZOSTAVAX did not prevent shingles as intended, and the patient subsequently contracted a persistent strain condition of herpes zoster. In July 2016, the patient was treated for a blistering vesicular outbreak, which was diagnosed as severe herpes zoster, or shingles. As a direct and proximate result of the ZOSTAVAX vaccine, and/or despite receiving ZOSTAVAX for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. The outcome is unknown. Additional information has been requested.
There were no adverse events/treatments needed for this encounter. Patient was given the Pfizer Bivalent 5-12 y/o, instead of receiving the Pfizer Bivalent 6mos-4 y/o . Patient remained in the office for 30 mins post administration with no complications. Department supervisor reached out to epidemiology and the state to confirm that dose will count towards the series/harm to patient if any.
I started have a white noise in my ear that made it very bothersome to sleep. I started having headaches, that were intense that lasted for a few minutes then would let up. I made an appointment to see an ENT who felt that I could try some different minerals to help alleviate the tinnitus. I went in for my heart checkup, the staff noticed an irregular rhythm. The heart has an extra beat every fourth beat. I feel this may be due to stress.
Received Flu shot and the next day had numbness in hands that went to fingers and progressed over the next week to the arm chest face and head. Went to ER and they did CT Scan, Spinal tap, X Ray bloodwork. Was in hospital for 3 days. Has not had Flu shot since 2003 - did not have H1N1. Now has tremors in hands- possible diagnosis MS.
Patient has two charts in system with different names and dates of birth. After provider verified information with parents. Patient was given DTap instead of Tdap.
It appears that the patient received a high-dose flu vaccine on 9/30/21 and then a regular flu vaccine on 11/17/21.
Approximately 11:10 am on 6/7/2021 Adverse event occurred during the 15 minute wait period following the vaccination.  Pt  c/o SOB, weakness , diaphoresis and pale.   Pt stated that she could not see and it was hard to breath. Pt stated that she has not eaten or had anything to drink today. Hx: was taken.  Pt had no known medical hx or allergies to meds
1-2 hrs p/vax pt noticed swelling to eye lids, no SOB, itching, no tongue/mouth swelling;DPH given;
Information has been received from two health professionals the authors of a literature article, concerning a female who had measles and rubella as a child, who was found to be rubella susceptible when she was pregnant in 1984, 1986, 1992 and 1998, and who was vaccinated with measles virus vaccine live  (Moraten) (+) mumps virus vaccine live (Jeryl Lynn) (+) rubella virus vaccine live (Wistar RA 27/3) (lot not reported) in the immediate postpartum period of her last pregnancy. It was also reported that she received no vaccines following the first three pregnancies. Her two older children (a boy, age 16, and a girl, age 13) are healthy. A third infant died at age 2 days from prematurity related complications. Subsequently, the pt developed severe arthritis of her knees, ankles, and hips following her own vaccination. The authors also reported that her baby boy developed autistic symptoms after his vaccination with measles virus vaccine live  (Moraten) (+) mumps virus vaccine live (Jeryl Lynn) (+) rubella virus vaccine live (Wistar RA 27/3) (WAES0404USA00066). Upon internal review, severe arthritis of her knees, ankles, and hips was considered to be an other important medical event (OMIC). Additional information is not expected.
pt recvd vax & exp inject site erythema 4-6 hrs later; The react was described as cellulitis; pt was treated w/Duricef for 10 days, warm compresses, APAP #3;
I started feeling a little under the weather at the time my daughter and granddaughter had COVID-19 so I decided to take a COVID test. I started feeling sluggish, coughing, no fever and a headache cooled off and it helped with the cough. I went to urgent care and was prescribed a course of PAXLOVID that I will be taking for the next five days.
sore arm; This is a spontaneous report from a contactable consumer or other non hcp (Patient's husband). This is report 2 of 2. The report is cross referenced to report ID: NMW0TC2Y. This is report 2 of 2. This re-port is in regard to the caller's wife. A female patient (reporter's wife) of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date as dose number unknown, single for covid-19 immunization. The patient medical history and concomitant medications were not reported. On an unspecified date, the patient experienced sore arm. It was re-ported, Caller was reporting on behalf of himself in regard to his experience with the COVID vaccine when he stated his wife also received the COVID vaccine and had no reaction at all other than her arm being sore. The clinical outcome for event was unknown.   No further details were provided or obtained. Information on the Lot/Batch number has been re-quested.
Patient received vaccination on 1/18/19- patient was later taken to ED for gaggin, became "floppy" and possibly had a bluish color around lips but still breathing. After the episode he was sleepy, parent claim the episode lasted about 5 minutes. AT ED presentation, patient was back to baseline, no diagnosis at visit. On 1/27/19 patient returned to ED for fevers, cough and noisy breathing and diagnosed with viral croup. Treated with vaponefrin and Decadron.
A large canker sore developed under my tongue; A large acne cyst on my left buttock.; This is a spontaneous report from a contactable consumer, the patient. A 62-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8737), via an unspecified route of administration in the arm right on 31Mar2021 at 15:15 (at the age of 62-year-old), as a single dose for COVID-19 immunisation. Medical history included functional heart murmur, bilirubin elevated and psoriasis. Concomitant medications included ECITALOP 10milligrams since an unknown date. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 01Apr2021 at 17:00, the patient experienced a large canker sore developed under tongue and a large acne cyst on left buttock. The adverse events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of the events a large canker sore developed under tongue and large acne cyst on left buttock was recovering.  No follow-up attempts are needed. No further information is expected.
10 1/2cm, 11 1/2cm redness, warm to touch.
Carditis; Eye inflammation; COVID-19; This spontaneous case was reported by a consumer and describes the occurrence of CARDITIS (Carditis) in a 50-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis. The occurrence of additional non-serious events is detailed below.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) injection for Rheumatoid arthritis.    No Medical History information was reported.   On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form and ADALIMUMAB (HUMIRA) (Subcutaneous) 1 dosage form once a week. In November 2021, the patient experienced COVID-19 (COVID-19). On an unknown date, the patient experienced CARDITIS (Carditis) (seriousness criterion medically significant) and EYE INFLAMMATION (Eye inflammation). At the time of the report, CARDITIS (Carditis), EYE INFLAMMATION (Eye inflammation) and COVID-19 (COVID-19) outcome was unknown.            No concomitant medication information was reported.  No treatment medication was reported.  It was unknown if patient was enrolled in a COVID-19 Vaccine Trial. Company comment This spontaneous case concerns a 50-year-old male patient with concomitant medication Adalimumab indicated for Rheumatoid arthritis, who experienced the unexpected serious, medically significant event of carditis and non-serious events of COVID-19 (AESI) and eye inflammation. The patient received a dose of mRNA-1273 on an unknown date, thus latency between vaccination and the event cannot be assessed. Adalimumab could lead to pericarditis. The medical history of Rheumatoid arthritis is associated with abnormal immunity and chronic inflammation that could be a contributory risk factor for carditis and eye inflammation. The event COVID-19 could also contribute to carditis and eye inflammation if their temporal relationship is known. The benefit-risk relationship of mRNA-1273 Vaccine is not affected by this report.; Sender's Comments: This spontaneous case concerns a 50-year-old male patient with concomitant medication Adalimumab indicated for Rheumatoid arthritis, who experienced the unexpected serious, medically significant event of carditis and non-serious events of COVID-19 (AESI) and eye inflammation. The patient received a dose of mRNA-1273 on an unknown date, thus latency between vaccination and the event cannot be assessed. Adalimumab could lead to pericarditis. The medical history of Rheumatoid arthritis is associated with abnormal immunity and chronic inflammation that could be a contributory risk factor for carditis and eye inflammation. The event COVID-19 could also contribute to carditis and eye inflammation if their temporal relationship is known. The benefit-risk relationship of mRNA-1273 Vaccine is not affected by this report.
This spontaneous report was received from a health care worker (medical assistant) refers to an unspecified number of patients of unknown age and gender. The patients' medical history, concurrent conditions and concomitant medications were not reported. On an unknown dates, the patients were vaccinated with improperly stored doses of VARIVAX which had lot # L010148 with expiry date: 24-MAR-2017 and lot # L016123 with expiry date: 06-MAY-2017, (dosing details not reported). No adverse effect was reported. The vaccine was exposed to a temperature excursion of -9.6 degree Celsius for 17 hours and 30 minutes, and it had previous temperature excursion of -13.5 degree Celsius for 3 hours and 30 minutes. The call was because of data logger. No further details provided. This is one of the three reports received from the same reporter. Additional information has been requested.
Patient fainted and had seizure like behavior for about 10 seconds.  Responded within 30 seconds.
Information has been received from a physician concerning a pt (demographics unspecified) who on 8/10/01 was vaccinated with a dose of MMRII. On 9/10/01, it was reported that "now" the pt has a "measles-like rash". The pt sought unspecified medical attention. Additional information has been requested.
On 02/12/2023, my husband began feeling ill. He didn't test positive for COVID-19 until 02/15/2023. Before that, we thought it was just a cold. On 02/18/2023, I felt a strange sort of illness coming on. It felt like a heaviness in my neck and shoulders. It felt as though I had something heavy sitting on my shoulders. I was also exhausted for no apparent reason. By the end of that day, I felt fluish with headache and body aches. I woke up the next day with a fever. I was pretty sure that I had COVID-19 since my husband had tested positive. Since it was a weekend, I was able to make a telehealth appointment. They prescribed Paxlovid and I was able to start it the same day. By the end of the course of Paxlovid, I was still testing positive. I felt better for one day and then I developed the world's worst head cold and my COVID-19 test was more strongly positive. I never had a fever the second time, but I felt more miserable with headache, cough, and runny nose. All of that lasted for around 10 days. I was sick for around 3 weeks overall.
fatigue; fever; headache beginning in late afternoon; chills beginning that night; This is a spontaneous report from a contactable other hcp (patient herself). A 28-years-old non pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: EL9264), via an unspecified route of administration, administered in left arm on 14Feb2021 10:30 (age at vaccination: 28 years) as DOSE 2, SINGLE for COVID-19 immunisation. The patient's medical history included allergic rhinitis and uterine fibroids. Concomitant medication(s) included mometasone furoate (FLONASE). The patient previously took pfizer biontech covid 19 vaccine on 24Jan2021 11:00, as DOSE 1, SINGLE for covid-19 immunisation. The patient past drug event included feraheme. On 14Feb2021 09:00, the patient experienced chills beginning that night, On 15Feb2021, the patient experienced fatigue, fever and headache beginning in late afternoon. The patient did not receive any treatment for the adverse events. The patient did not have covid prior to vaccination nor was tested since vaccination. The outcome of all the events was recovered on an unknown date in 2021.  Follow-up attempts completed. No further information expected.
Initial and follow up information has been received from a licensed practical nurse concerning a 46 year old female with no known drug allergies and with hypertension who on 6/12/04 was vaccinated with a first dose of MMR (lot # 646906/0956N) SQ into the left arm. There was no illness at the time of vaccination. Concomitant therapy was unknown. In June 2004, after vaccination, the patient developed a measles-like rash all over her body. It was reported that per the patient family physician's she developed measles. The patient was an immigrant and left the urgent care center prior to a full examination. It was reported that all labs at a prior examination were within normal limits. The outcome of the event was unknown. Additional information has been requested.
Patient presented with a vaccine card J&J 05/11/2021 asking for booster.  Registration found an additional two doses of pfizer on 04/03/2021 and 04/24/2021 at outside pharmacy, patient admitted he got those two doses (not on his vaccine card ). EHR noted pt received Pfizer on 12/1/21 which patient denied receiving.  Pt received Pfizer booster dose on  4/28/22. No side effect noted to writer post-vaccination.  On further review, staff discovered additional forms in pt chart and possible that pt received Pfizer dose on 12/1/21 despite pt denying not getting it.
A couple days after the vaccine, I went to my OB/GYN for cysts on my groin (but that started prior to the vaccine)  I was prescribed an antibiotic (Bactrim).  Four days after the vaccine, I was light headed, dizzy and fatigued.  I have headaches.  My blood pressure dropped to 80/59...my blood kept going up and down, therefore, I didn't take my blood pressure medication until my blood pressure reached a normal range and stayed for a day.  Since my blood pressure is hovering around 121/67.    Today, I still have minor headaches but no dizziness or light headedness.
Information was identified on the internet, from the mother of an 11 year old female patient with a family history of ovarian, uterine, and cervical issues.  The mother reported that her daughter "just got hers this year," referring to being vaccinated with an unspecified human papillomavirus vaccine (manufacturer, lot number, dosage, and route of administration not provided).  The mother reported that her daughter had no issue other than some lingering injection site soreness.  The outcome of the lingering injection site soreness was not provided.  No further adverse event information was reported. Additional information is not expected.
large (11x12cm) area of non-tender induration, erythema w/onset 2 days (36hrs) p/vax;pt afeb;non-cellulitic, local rxn;
Abdominal pain, tingling of legs, difficulty walking started on 1/7/2010 which progressed to paralysis of lower limbs and loss of sensation, suspecting transverse myelitis, was in PICU for 6 days, on high dose steroids and plasmapheresis, still sdmitted in hospital, no clinical improvement.
This spontaneous report as received from a certified medical assistant refers to approximately 30 patients of unknown ages. On an unknown date, the patient were vaccinated with 0.5 ml doses of GARDASIL (Lot # reported as J00735) IM. The medical assistant stated that it was not unusual for patients to experience tenderness, soreness and or redness at the injection site after receiving GARDASIL or other unspecified vaccines. The medical assistant stated that they had 30 doses of GARDASIL lot # J00735 and all of those doses had been administered. On an unknown date, some of those 30 patients might have experienced tenderness, soreness and redness at the injection site after receiving GARDASIL lot J00735 but the medical assistant did not remember a specific adverse event associated with that lot number. The outcome of tenderness and soreness at the injection site and redness at the injection site was unknown. Additional information has been requested.
Fatigue, throbbing headache, body aches, joint pain, arm pain where shot was. Fatigue worsened throughout the first day and carried into the second as well as the headaches.
Fever, NauseaVomiting, HYPERtension, Angina, Tachycardia, Chest pain radiating down L arm with hypertensive issues at  199/109. Narrative: Employee reports was taken to hospital and stayed for 2 days. Missed 2 days of work due to symptoms.  Other Relevant History:
15 min after shot immediate tension headache pressure on sides of both heads. Tingling in head, and limbs were heavy and tingling fingers. Had trouble sleeping. Heart rate was beating high.
3 days post inject devel myalgias w/intermittent fever w/hives & chills; taking advil;
Information has been received from a physician concerning a patient who on an unspecified dates was vaccinated orally with three doses of ROTATEQ. Subsequently the patient was diagnosed with intussusception. The patient visited the physician's office for medical attention. At the time of reporting, the outcome was unknown. Upon internal review intussusception was considered to be an other important medical events. Additional information has been requested.  5/21/09 Received vaccine & PCP medical records which included hospital H&P. FINAL DX: Intussusception, enema reduced Records reveal patient experienced abdominal pain & decreased energy x 1 day.  Had URI & loose stools x 1 wk.  Saw PCP on 5/11 & sent to ER.  Observed overnight s/p enema reduction.  Improved & d/c to home.  6/4/09 Hospital records received DOS 5/11-12/09. FINAL DX: Intussusception, enema reduced. Post vaccination acute onset of abdominal pain. Loose stools. Decreased energy. Rhinorrhea and cough.   8/27/09 Received ICD9 codes for 5/11-5/12 admit: 560.0, intussusception; 465.9 acute URI NOS; 789.00 abdominal pain, unspecified site.
Welts/large hives on buttocks, thighs that were red and itchy that started about 3 hours after receiving the vaccine. Few Smaller itchy red bumps  scattered throughout torso. This last for 3 days and then resolved.
Arm soreness; This is a spontaneous report from a non-contactable consumer, the patient. A 30-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via unspecified route of administration on an unknown date as a single dose for COVID-19 immunisation. The patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EL3247) via unspecified route of administration on 22Mar2021 at 14:00 (at the age of 30-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Concomitant medications were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On an unknown date after first dose, the patient experienced arm soreness. The patient also experienced arm soreness on 22Mar2021 at 16:00. The patient stated that it felt like onset of arm soreness was faster when compared with vaccine 1 and magnitude of pain was seemingly lower than vaccine 1. The patient did not receive any treatment for the event. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of arm soreness was recovering at the time of report.   No follow-up attempts are needed. No further information is expected.
Adverse reaction left arm feels tight and is swollen shoulder to elbow, complained of itching. No redness noted but arm felt warm.